Cancer is our SPECIALTY. Healing is our PASSION.
Integrated on-site cancer care options help streamline patient testing and facilitate the patient care cycle. Our efficient all-in-house services save patients time and resources while enabling us to easily keep you updated on your patient’s progress.
Each of our cancer centers is easily accessible and conveniently located close to home. Our relaxed, family-oriented environment and caring staff help put patients and their families at ease. We take pride in our patient satisfaction and quality of care. Our Staff includes physicians and support staff fluent in Spanish as well as several other languages.
We have simplified the patient referral process to save you time and to ensure we see your patient as quickly as possible. Our referral process is completed in two easy ways:
By Telephone - A well-trained Medical Representative will be there to meet your needs. You can find the appropriate number on our locations list.
- By Fax - Complete our referral form and fax it to the office of your choice. Within 24 hours, we will contact your staff to advise you of the date and time of your patient’s scheduled appointment. View locations list.
If you need more information about our clinical trials program or if you have a patient who might meet eligibility requirements for a specific research study, please see our Clinical Research & Trials section.
Cancer in the News
- Adaptimmune announces interim results from pilot trial of its engineered NY-ESO T cells targeting synovial sarcoma
- Australian government commitment needed to reduce cancer care inequalities
- Optimal centralised cancer care can narrow rural vs urban gap
- New report highlights potential links between weight, physical activity and breast cancer survival
- Breast reconstruction after mastectomy: expansion significantly faster with AeroForm expanders than traditional saline expanders
- A good diet before diagnosis is linked with lower mortality among OVCA survivors
- Personalized cellular therapy achieves complete remission in 90 percent of acute lymphoblastic leukemia patients studied
- Modeling tumor dormancy
- Simple test may predict surgical wound healing complications after removal of soft tissue sarcomas
- Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer
- MD Anderson study first to compare treatments, survival benefits for early-stage lung cancer
- Cancer medicine: New, improved, expensive and exploited?
- Personalized ovarian cancer vaccines set for human trials
- Drug-resistant candida glabrata infection in cancer patients